7 Recruiting Breast Neoplasms Phase 1 Clinical Trials
Active phase 1 studies for breast neoplasms enrolling across the USA. Verify eligibility and contact site coordinators.
All Breast Neoplasms studiesPhase 1 Studies for Breast Neoplasms
🔵 Active, Not Recruiting Phase1 / Phase2
Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer
📍 10 sites incl TX, WA, VA, and NV — Dallas, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
📍 Highlands Oncology Group - Duplicate 2 — Rogers, Arkansas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast
📍 Mount Sinai Beth Israel Comprehensive Cancer Center West — New York, New York
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
A Study of DM001 in Patients With Advanced Solid Tumors
📍 Sarah Cannon Research Institute (SCRI) — Nashville, Tennessee
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
📍 Providence Medical Foundation — Fullerton, California
View Study & Checklist ➔ 🟢 Recruiting Phase1
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
📍 City of Hope — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
📍 University of Colorado Anschutz Medical Campus ( Site 0057) — Aurora, Colorado
View Study & Checklist ➔